Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
- DOI
- 10.1136/jnnp-2026-338694
- Published
- 2026 Sep 14
- Container
- Journal of neurology, neurosurgery, and psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jnnp-2026-338694,
title = {Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.},
author = {Carvajal R and Marcialis C and Tur C and Otero-Romero S and Roos I and Pappolla A and Novak F and Cobo-Calvo A and Ariño H and Arrambide G and Bollo L and Casallas-Vanegas A and Castilló J and Comabella M and Driemeyer C and Elosua I and Fadrique C and Galán I and Grávalos M and La Puma D and Masot A and Midaglia L and Molina-Goicoechea M and Mongay-Ochoa N and Rodríguez-Acevedo B and Río J and Tagliani P and Vidal-Jordana A and Vilaseca-Jolonch A and Zabalza A and Pugliatti M and Sastre-Garriga J and Kalincik T and Montalban X and Tintore M},
year = {2026},
journal = {Journal of neurology, neurosurgery, and psychiatry},
doi = {10.1136/jnnp-2026-338694},
url = {https://doi.org/10.1136/jnnp-2026-338694}
}RIS
TY - JOUR TI - Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS. AU - Carvajal R AU - Marcialis C AU - Tur C AU - Otero-Romero S AU - Roos I AU - Pappolla A AU - Novak F AU - Cobo-Calvo A AU - Ariño H AU - Arrambide G AU - Bollo L AU - Casallas-Vanegas A AU - Castilló J AU - Comabella M AU - Driemeyer C AU - Elosua I AU - Fadrique C AU - Galán I AU - Grávalos M AU - La Puma D AU - Masot A AU - Midaglia L AU - Molina-Goicoechea M AU - Mongay-Ochoa N AU - Rodríguez-Acevedo B AU - Río J AU - Tagliani P AU - Vidal-Jordana A AU - Vilaseca-Jolonch A AU - Zabalza A AU - Pugliatti M AU - Sastre-Garriga J AU - Kalincik T AU - Montalban X AU - Tintore M PY - 2026 JO - Journal of neurology, neurosurgery, and psychiatry DO - 10.1136/jnnp-2026-338694 UR - https://doi.org/10.1136/jnnp-2026-338694 ER -
APA
R, C., C, M., C, T., S, O., I, R., A, P., F, N., A, C., H, A., G, A., L, B., A, C., J, C., M, C., C, D., I, E., C, F., I, G., M, G., D, L. P., A, M., L, M., M, M., N, M., B, R., J, R., P, T., A, V., A, V., A, Z., M, P., J, S., T, K., X, M., & M, T. (2026). Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2026-338694
Source records
- pubmed · retrieved 2026-09-25T23:28:19.329Z